Abstract:OBJECTIVE: Synovial sarcoma (SS) is a malignant soft tissue sarcoma and its natural history is a long, indolent clinical course followed by high rate of local recurrence and distant metastasis. Current therapies are still limited in increasing satisfactory of 5-year survival, especially for patients with recurrence and metastasis. Accordingly, finding new therapeutic drug for SS treatment is clinically urgent need. Diallyl trisulfide (DATS), a bioactive compound derived from garlic, is reported as a promising anti-cancer agent for various carcinomas. However, its effect on anti-SS remains unknown. This study investigated the anti-SS effect of DATS in human synovial sarcoma SW982 cells.METHODS: CCK-8 assay were used to examine the cell viability. High-content Imaging System was used to examine the apoptosis, intracellular ROS and autophagy. Flow cytometry was used to detect cell cycle. qPCR and Western blot were used to examine the expression of related mRNA and protein. High-throughput RNA-sequencing and bio-information analysis were used to investigate the mRNA profiling.RESULTS: The results showed a suppressive effect of DATS on tumor biology of SW982 cells including inducing apoptosis, triggering G2/M cell cycle arrest, elevating intracellular ROS and damaging mitochondria. Further high-throughput RNA-sequencing analysis clarified a comprehensive molecular portrait for DATS-induced transcriptional regulation. Besides, protein-protein interaction (PPI) analysis demonstrated that a network consisted of FOXM1, CCNA2, CCNB1, MYBL2, PLK1 and CDK1 might be response for DATS-induced G2/M cell cycle arrest and increased intracellular ROS. Notably, protein feature analysis revealed structure enrichment in microtubule network like kinesin motors domain, and tubulin domain. Molecular function analysis suggested that DATS-induced dysfunction of microtubule network might be the major cause for its effect on cell cycle arrest and successive apoptosis. Furthermore, 28 hub genes (including KIF2C, PLK1, CDK1, BIRC5, CCNB2, CENPF, TPX2, TOP2A and so on) were determined. Finally, pathway analysis showed that DATS-induced differentially expressed genes were mainly involved in cell cycle.CONCLUSION: Collectively, our findings for the first time provided the DATS-induced cellular response and transcriptional profiling of SW982 cells, which proposes that suppression of DATS on SS is multi-targeted and represent a therapeutic evidence for SS.

Knockdown fusion gene SYT-SSX expression by RNAi induces apoptosis in synovial sarcoma cells line HS-SY-Ⅱ

Downregulation of Ss18-Ssx1 Expression by Small Interfering Rna Inhibits Growth and Induces Apoptosis in Human Synovial Sarcoma Cell Line Hs-Sy-Ii in Vitro

The Effect of SYT-SSX and Extracellular Signal-Regulated Kinase (ERK) on Cell Proliferation in Synovial Sarcoma

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

Expression and Function Evaluation of SYT-SSX1 and SYT-SSX2 Genes in Synovial Sarcoma

[Growth Inhibition of MG-63 Cells by Cyclin A2 Gene-Specific Small Interfering RNA].

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

Effects of selective inactivation of DNA-PKcs gene with small interfering RNA on radiosensitivity of human pancreatic carcinoma cell line

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

[Influence of RNA Interference on MSI-2 Gene in THP-1 Cell and Expression of NUMB].

Gene Expression Profile by Blocking the SYT-SSX Fusion Gene in Synovial Sarcoma Cells. Identification of XRCC4 As a Putative SYT-SSX Target Gene

The role of SYT-SSX fusion genes in the development of synovial sarcoma and their prognostic value

In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling

siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.

Syt-Ssx Is Critical For Cyclin D1 Expression In Synovial Sarcoma Cells: A Gain Of Function Of The T(X;18)(P11.2;Q11.2) Translocation

SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling

[Construction and identification of small interfering RNA expression plasmid targeting Sox9 and the function to cell growth and apoptosis of human chondrosarcoma cells HTB94]

The Clinical Implication of SS18 -SSX Fusion Gene in Synovial Sarcoma

[Detection of SYT-SSX Fusion Gene in Paraffin-Embedded Tissues and Its Clinicopathologic Significance for Synovial Sarcoma].

Detection of SYT - SSX Fusion Gene Transcripts in Synovial Sarcoma and Its Correlation with Histological Phenotypes

[Effect of EPHA2-siRNA Plasmid on Biological Behavior of Human Osteosarcoma Cells in Vitro].